CLINICAL_TRIALS
research
· 2012-03-15
Clinical Trial Update: Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
Summary
A completed genetic study assessing gene mutations in participants with Von Hippel-Lindau syndrome or at risk, previously enrolled in NIH trial NCI-99-C-0053.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Kidney Cancer, Von Hippel-lindau Syndrome | Status: COMPLETED